Facebook
Twitter
LinkedIn
Forward2022 MSS Pharmacy Leadership Conference
Subject matter experts that have direct experience implementing the following ideal practices are presenting:
- Consulting experience in overcoming hospital budget shortfalls including enhancing revenue with new programs and process.
- Suppository preparation in the hospital setting.
- Pharmacy technician development and training to run a medication history program
- Implementation of tenecteplase dosing program for AIS.
- Strategies to advance pharmacy practice.
- Biosimilar contracting and identification of savings
Faculty will present information with a focus on how the attendee can use the information to implement it in their setting, including key takeaway points with each presentation. The audience will be engaged in polling and can ask questions to further their knowledge and confidence.
Target Audience
This activity is intended for pharmacists and pharmacy technicians.
Learning Objectives
Pharmacists learning objectives
At the conclusion of this activity, pharmacists should be able to:
- Describe two strategies to deliver additional value to your health system.
- Summarize two pharmacy-focused actions to enhance health system revenue.
- Discuss the value of preparing indomethacin suppositories to prevent ERCP induced pancreatitis.
- Describe the training process to establish a medication history program.
- Explain key evidence supporting the use of tenecteplase in ischemic stroke.
- Describe best practices to safely implement the use tenecteplase in acute ischemic stroke.
- Describe three issues that health system pharmacy is facing and corresponding opportunities to address them.
- Outline biosimilar pipeline opportunities with oncology, retinal, and adalimumab biosimilars therapies.
- Identify two best practices that can help improve current biosimilar uptake at your health system.
- Describe one action item you can complete to help prepare for adalimumab biosimilar launches.
Pharmacy technician learning objectives
At the conclusion of this activity, pharmacy technicians should be able to:
- Describe two strategies to deliver additional value to your health system.
- Summarize two pharmacy-focused actions to enhance health system revenue.
- Discuss the value of preparing indomethacin suppositories to prevent ERCP induced pancreatitis.
- Describe the training process to establish a medication history program.
- Describe best practices to safely implement the use tenecteplase in acute ischemic stroke.
- Describe three issues that health system pharmacy is facing and corresponding opportunities to address them.
- Outline biosimilar pipeline opportunities with oncology, retinal, and adalimumab biosimilars therapies.
Identify two best practices that can help improve current biosimilar uptake at your health system. - Describe one action item you can complete to help prepare for adalimumab biosimilar launches.
Acknowledgement of Support
This activity was funded in part by Mid-America Service Solutions (MSS) LLC.
Additional Information
| Attachment | Size |
|---|---|
 Helpful Tips for Users - Vizient CE System.pdf | 134.81 KB |
Faculty
Karen Barrow, RN, MHA, FACHE
Associate Director
BRG
James Braun, PharmD, BCCCP
Neurosciences Pharmacy Clinical Specialist
SSM Health Saint Louis University Hospital – St. Louis
Joel Hennenfent, PharmD, MBA, BCPS, FASHP
SVP
Pharmacy Member Services
Vizient, Inc.
Ashlie Kallal, PharmD, CLSSBB
Supervisor, Medication Safety, Pharmacy Department
Springfield Memorial Hospital
Steven Kennedy, PharmD, CSP
Senior Consulting Solutions Director, Ambulatory
Pharmacy Advisory Solutions
Vizient, Inc.
Toby Nnamdi, PharmD, MBA, BCPS
System Service Director, Pharmacy
Southern Illinois Healthcare
Melanie Ryan, PharmD
Pharmacy Director
Methodist Jennie Edmundson Hospital
Shannon Smallwood, PharmD, BCPS
Senior Pharmacy Executive
Vizient, Inc.
Greg Teale, PharmD, BCPS
Vice President, Pharmacy
Saint Luke's Health System
Jerome Wohleb, PharmD, MBA, FASHP, FAzPA
Pharmacy Director
Bryan Health
Planning committee
Julie Beckman, PharmD
Pharmacy Executive Director
IHN Network
Pharmacy Member Solutions
Vizient, Inc.
Gretchen Brummel, PharmD, BCPS
Pharmacy Executive Director
Center for Pharmacy Practice Excellence
Vizient, Inc.
Michelle Crump, ABA, CPhT
Pharmacy Buyer
Newman Regional Health
Leigh Ann Milburn, PharmD, BCPS
Clinical Pharmacy Coordinator
Department of Pharmacy
Saint Luke’s Health System, Kansas City
Alexander Parish, PharmD, MBA
Sr Project Manager, Pharmacy Networks
Pharmacy Member Solutions
Vizient, Inc.
Karen Smethers, BS, PharmD, BCOP
Senior Director
MSS Pharmacy Network
Pharmacy Member Services
Vizient, Inc.
Identification, Mitigation, and Disclosure of Relevant Financial Relationships
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
Disclosure of Financial Relationships:
Absence of Relevant Financial Relationships
Vizient, Inc., Jointly Accredited for Interprofessional Continuing Education, defines companies to be ineligible as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.
No one in a position to control the content of this educational activity have relevant financial relationships with ineligible companies.
Joint Accreditation Statement:
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Designation Statement(s):
PHARMACY
Vizient, Inc. designates this activity for a maximum of 4.00 ACPE credit hours.
UAN: JA0006103-0000-22-136-L04-P
UAN: JA0006103-0000-22-136-L04-T
Available Credit
- 4.00 ACPE Pharmacist
- 4.00 ACPE Pharmacy Technician